Pharmaceutical Nanotechnology
publishes original manuscripts, reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterisation and pharmaceutical (or diagnostic) application of materials at the nanoscale. The nanoscale
is defined as a size range of below 1 µm. Scientific
findings related to micro and macro systems with functionality
residing within features defined at the nanoscale are also
within the scope of the journal. Manuscripts detailing the
synthesis, exhaustive characterisation, biological evaluation,
clinical testing and/ or toxicological assessment of nanomaterials
are of particular interest to the journal’s readership.
Articles should be self contained, centred around a well
founded hypothesis and should aim to showcase the pharmaceutical/
diagnostic implications of the nanotechnology approach.
Manuscripts should aim, wherever possible, to demonstrate
the in vivo impact of any nanotechnological intervention.
As reducing a material to the nanoscale is capable of fundamentally
altering the material’s properties, the journal’s
readership is particularly interested in new characterisation
techniques and the advanced properties that originate from
this size reduction. Both bottom up and top down approaches
to the realisation of nanomaterials lie within the scope
of the journal.
